HMA treatment patterns among patients with MDS who received HMA. (A) Azacitidine. (B) Decitabine. Each histogram bar represents total number of patients in that treatment cycle (that is 28-day treatment period). The color-coded sections in each histogram bar represents the distribution by proportion of patients who received complete cycle or incomplete cycle or had a treatment gap or interruption in that cycle.